BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000708 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 13, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
445,767
Total Value
$16,864,343.25
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 9, 2026 | Exercise/Conversion | 19,000 | $8.45 | $160,550.00 | 27,383 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 9, 2026 | Exercise/Conversion | 112,422 | $29.00 | $3,260,238.00 | 139,805 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 9, 2026 | Exercise/Conversion | 17,167 | $16.75 | $287,547.25 | 156,972 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 9, 2026 | Sale | 36,167 | $84.00 | $3,038,028.00 | 120,805 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 9, 2026 | Sale | 112,422 | $90.00 | $10,117,980.00 | 8,383 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jul 9, 2026 | Exercise/Conversion | 19,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jul 9, 2026 | Exercise/Conversion | 112,422 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jul 9, 2026 | Exercise/Conversion | 17,167 | $0.00 | $0.00 | 0 | Direct | โ | View Details |